{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:27:03Z","timestamp":1789043223501,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,26]]},"DOI":"10.7759\/cureus.93271","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T12:41:01Z","timestamp":1758890461000},"source":"Crossref","is-referenced-by-count":3,"title":["Chronic Cardiovascular Disorders Associated With COVID-19: A Literature Review"],"prefix":"10.7759","author":[{"given":"Adam","family":"Dudek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Bursy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Szkudlarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Linkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Fabiszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Starosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V'kovski P","year":"2021","unstructured":"V'kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021, 19:155-70. 10.1038\/s41579-020-00468-6","journal-title":"Nat Rev Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson CB","year":"2022","unstructured":"Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022, 23:3-20. 10.1038\/s41580-021-00418-x","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154497","article-title":"COVID-19, post-acute COVID-19 syndrome (PACS, \"long COVID\") and post-COVID-19 vaccination syndrome (PCVS, \"post-COVIDvac-syndrome\"): similarities and differences","volume":"246","author":"Scholkmann F","year":"2023","unstructured":"Scholkmann F, May CA. COVID-19, post-acute COVID-19 syndrome (PACS, \"long COVID\") and post-COVID-19 vaccination syndrome (PCVS, \"post-COVIDvac-syndrome\"): similarities and differences. Pathol Res Pract. 2023, 246:154497. 10.1016\/j.prp.2023.154497","journal-title":"Pathol Res Pract"},{"key":"ref4","unstructured":"COVID-19 cases, world. (2025). https.\/\/covid19.who.int\/."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01136-X","article-title":"Long COVID: a clinical update","volume":"404","author":"Greenhalgh T","year":"2024","unstructured":"Greenhalgh T, Sivan M, Perlowski A, Nikolich J\u017d. Long COVID: a clinical update. Lancet. 2024, 404:707-24. 10.1016\/S0140-6736(24)01136-X","journal-title":"Lancet"},{"key":"ref6","unstructured":"COVID-19 rapid guideline. managing the long-term effects of COVID-19. (2020). https:\/\/www.nice.org.uk\/guidance\/ng188."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/v15010175","article-title":"Risk factors of severe COVID-19: a review of host, viral and environmental factors","volume":"15","author":"Zsichla L","year":"2023","unstructured":"Zsichla L, M\u00fcller V. Risk factors of severe COVID-19: a review of host, viral and environmental factors. Viruses. 2023, 15:175. 10.3390\/v15010175","journal-title":"Viruses"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.12603","article-title":"Persistent symptoms in patients after acute COVID-19","volume":"324","author":"Carf\u00ec A","year":"2020","unstructured":"Carf\u00ec A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020, 324:603-5. 10.1001\/jama.2020.12603","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac031","article-title":"Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus","volume":"43","author":"Raman B","year":"2022","unstructured":"Raman B, Bluemke DA, L\u00fcscher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022, 43:1157-72. 10.1093\/eurheartj\/ehac031","journal-title":"Eur Heart J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvac115","article-title":"Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint scientific statement of the ESC Working Groups on cellular biology of the heart and myocardial and pericardial diseases","volume":"119","author":"Gy\u00f6ngy\u00f6si M","year":"2023","unstructured":"Gy\u00f6ngy\u00f6si M, Alcaide P, Asselbergs FW, et al.. Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint scientific statement of the ESC Working Groups on cellular biology of the heart and myocardial and pericardial diseases. Cardiovasc Res. 2023, 119:336-56. 10.1093\/cvr\/cvac115","journal-title":"Cardiovasc Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.01.004","article-title":"Multi-organ proteomic landscape of COVID-19 autopsies","volume":"184","author":"Nie X","year":"2021","unstructured":"Nie X, Qian L, Sun R, et al.. Multi-organ proteomic landscape of COVID-19 autopsies. Cell. 2021, 184:775-91.e14. 10.1016\/j.cell.2021.01.004","journal-title":"Cell"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.21802\/gmj.2023.3.7","article-title":"A case of long COVID-19 myocarditis with asymptomatic manifestation in a young male","volume":"30","author":"Savchenko O","year":"2023","unstructured":"Savchenko O, Tyravska Y, Moshkovska Y, Pliskevych D, Altunina N, Lizogub V. A case of long COVID-19 myocarditis with asymptomatic manifestation in a young male. Galician Med J. 2023, 30:202337. 10.21802\/gmj.2023.3.7","journal-title":"Galician Med J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2021.101366","article-title":"Myocardial fibrosis after COVID-19 infection and severe sinus arrest episodes in an asymptomatic patient with mild sleep apnea syndrome: a case report and review of the literature","volume":"32","author":"Lampropoulos CE","year":"2021","unstructured":"Lampropoulos CE, Mavrogeni S, Dervas A, et al.. Myocardial fibrosis after COVID-19 infection and severe sinus arrest episodes in an asymptomatic patient with mild sleep apnea syndrome: a case report and review of the literature. Respir Med Case Rep. 2021, 32:101366. 10.1016\/j.rmcr.2021.101366","journal-title":"Respir Med Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2021.110641","article-title":"Highly expressed ACE-2 receptors during pregnancy: a protective factor for SARS-COV-2 infection?","volume":"153","author":"Figueiro-Filho EA","year":"2021","unstructured":"Figueiro-Filho EA, Hobson SR, Farine D, Yudin MH. Highly expressed ACE-2 receptors during pregnancy: a protective factor for SARS-COV-2 infection?. Med Hypotheses. 2021, 153:110641. 10.1016\/j.mehy.2021.110641","journal-title":"Med Hypotheses"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jelectrocard.2020.07.007","article-title":"Electrocardiographic signs of acute right ventricular hypertrophy in patients with COVID-19 pneumonia: a clinical case series","volume":"62","author":"Mart\u00ednez-Mateo V","year":"2020","unstructured":"Mart\u00ednez-Mateo V, Fern\u00e1ndez-Anguita MJ, Paule A. Electrocardiographic signs of acute right ventricular hypertrophy in patients with COVID-19 pneumonia: a clinical case series. J Electrocardiol. 2020, 62:100-2. 10.1016\/j.jelectrocard.2020.07.007","journal-title":"J Electrocardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.83927","article-title":"Myocardial fibrosis in a recovered COVID-19 patient: a case indicating prior myocarditis","volume":"17","author":"Janonyt\u0117 U","year":"2025","unstructured":"Janonyt\u0117 U, Cie\u0161kait\u0117 SG, S\u0117lenyt\u0117 M, \u017debrauskait\u0117-Keblikien\u0117 G, Lapinskas T, \u017daliaduonyt\u0117 D. Myocardial fibrosis in a recovered COVID-19 patient: a case indicating prior myocarditis. Cureus. 2025, 17:e83927. 10.7759\/cureus.83927","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.3557","article-title":"Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)","volume":"5","author":"Puntmann VO","year":"2020","unstructured":"Puntmann VO, Carerj ML, Wieters I, et al.. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020, 5:1265-73. 10.1001\/jamacardio.2020.3557","journal-title":"JAMA Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021211162","article-title":"Cardiac MRI in patients with prolonged cardiorespiratory symptoms after mild to moderate COVID-19","volume":"301","author":"Kravchenko D","year":"2021","unstructured":"Kravchenko D, Isaak A, Zimmer S, et al.. Cardiac MRI in patients with prolonged cardiorespiratory symptoms after mild to moderate COVID-19. Radiology. 2021, 301:E419-25. 10.1148\/radiol.2021211162","journal-title":"Radiology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytaf100","article-title":"A case report of long COVID-19 and chronic active myocarditis","volume":"9","author":"Elia S","year":"2025","unstructured":"Elia S, De Vecchi S, D'Amario D, Patti G. A case report of long COVID-19 and chronic active myocarditis. Eur Heart J Case Rep. 2025, 9:ytaf100. 10.1093\/ehjcr\/ytaf100","journal-title":"Eur Heart J Case Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2015.03.029","article-title":"2015 Heart Rhythm Society Expert Consensus Statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope","volume":"12","author":"Sheldon RS","year":"2015","unstructured":"Sheldon RS, Grubb BP 2nd, Olshansky B, et al.. 2015 Heart Rhythm Society Expert Consensus Statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015, 12:e41-63. 10.1016\/j.hrthm.2015.03.029","journal-title":"Heart Rhythm"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.21542\/gcsp.2022.13","article-title":"Postural orthostatic tachycardia syndrome and post-acute COVID-19","volume":"2022","author":"Amekran Y","year":"2022","unstructured":"Amekran Y, Damoun N, El Hangouche AJ. Postural orthostatic tachycardia syndrome and post-acute COVID-19. Glob Cardiol Sci Pract. 2022, 2022:e202213. 10.21542\/gcsp.2022.13","journal-title":"Glob Cardiol Sci Pract"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2021.01.009","article-title":"Long-haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience","volume":"3","author":"Johansson M","year":"2021","unstructured":"Johansson M, St\u00e5hlberg M, Runold M, et al.. Long-haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. JACC Case Rep. 2021, 3:573-80. 10.1016\/j.jaccas.2021.01.009","journal-title":"JACC Case Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.15441\/ceem.22.409","article-title":"Post-acute sequelae of SARS-CoV-2 syndrome presenting as postural orthostatic tachycardia syndrome","volume":"10","author":"Diekman S","year":"2023","unstructured":"Diekman S, Chung T. Post-acute sequelae of SARS-CoV-2 syndrome presenting as postural orthostatic tachycardia syndrome. Clin Exp Emerg Med. 2023, 10:18-25. 10.15441\/ceem.22.409","journal-title":"Clin Exp Emerg Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2021.100100","article-title":"Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms","volume":"4","author":"Wallukat G","year":"2021","unstructured":"Wallukat G, Hohberger B, Wenzel K, et al.. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun. 2021, 4:100100. 10.1016\/j.jtauto.2021.100100","journal-title":"J Transl Autoimmun"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-020-00727-9","article-title":"A case report of postural tachycardia syndrome after COVID-19","volume":"30","author":"Miglis MG","year":"2020","unstructured":"Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn DI, Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clin Auton Res. 2020, 30:449-51. 10.1007\/s10286-020-00727-9","journal-title":"Clin Auton Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.5837\/bjc.2022.003","article-title":"Observational case series of postural tachycardia syndrome (PoTS) in post-COVID-19 patients","volume":"29","author":"Gall NP","year":"2022","unstructured":"Gall NP, James S, Kavi L. Observational case series of postural tachycardia syndrome (PoTS) in post-COVID-19 patients. Br J Cardiol. 2022, 29:3. 10.5837\/bjc.2022.003","journal-title":"Br J Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2021.102828","article-title":"Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - part 1","volume":"235","author":"Vernino S","year":"2021","unstructured":"Vernino S, Bourne KM, Stiles LE, et al.. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - part 1. Auton Neurosci. 2021, 235:102828. 10.1016\/j.autneu.2021.102828","journal-title":"Auton Neurosci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.5606\/tftrd.2022.11435","article-title":"COVID-19, cardiac involvement and cardiac rehabilitation: insights from a rehabilitation perspective - state of the art","volume":"68","author":"Sonel Tur B","year":"2022","unstructured":"Sonel Tur B, K\u00f6seo\u011flu BF, Kutay Ordu G\u00f6kkaya N, et al.. COVID-19, cardiac involvement and cardiac rehabilitation: insights from a rehabilitation perspective - state of the art. Turk J Phys Med Rehabil. 2022, 68:317-35. 10.5606\/tftrd.2022.11435","journal-title":"Turk J Phys Med Rehabil"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-243585","article-title":"COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine","volume":"14","author":"O'Sullivan JS","year":"2021","unstructured":"O'Sullivan JS, Lyne A, Vaughan CJ. COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine. BMJ Case Rep. 2021, 14:243585. 10.1136\/bcr-2021-243585","journal-title":"BMJ Case Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/jgf2.670","article-title":"Treatment of long COVID complicated by postural orthostatic tachycardia syndrome-case series research","volume":"25","author":"Tsuchida T","year":"2024","unstructured":"Tsuchida T, Ishibashi Y, Inoue Y, et al.. Treatment of long COVID complicated by postural orthostatic tachycardia syndrome-case series research. J Gen Fam Med. 2024, 25:53-61. 10.1002\/jgf2.670","journal-title":"J Gen Fam Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000043333","article-title":"Successful treatment of long-COVID postural tachycardia syndrome with epipharyngeal abrasive therapy in an adolescent patient: a case report","volume":"104","author":"Takezawa H","year":"2025","unstructured":"Takezawa H. Successful treatment of long-COVID postural tachycardia syndrome with epipharyngeal abrasive therapy in an adolescent patient: a case report. Medicine (Baltimore). 2025, 104:e43333. 10.1097\/MD.0000000000043333","journal-title":"Medicine (Baltimore)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26010123","article-title":"Hypertension: a continuing public healthcare issue","volume":"26","author":"Goorani S","year":"2024","unstructured":"Goorani S, Zangene S, Imig JD. Hypertension: a continuing public healthcare issue. Int J Mol Sci. 2024, 26:123. 10.3390\/ijms26010123","journal-title":"Int J Mol Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy JW","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, et al.. 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024, 45:3912-4018. 10.1093\/eurheartj\/ehae178","journal-title":"Eur Heart J"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/167482","article-title":"Long COVID and its cardiovascular consequences: what is known?","volume":"33","author":"Sk\u0142adanek JA","year":"2024","unstructured":"Sk\u0142adanek JA, Le\u015bkiewicz M, Gumi\u0119\u017cna K, et al.. Long COVID and its cardiovascular consequences: what is known?. Adv Clin Exp Med. 2024, 33:299-308. 10.17219\/acem\/167482","journal-title":"Adv Clin Exp Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1098","article-title":"Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study","volume":"373","author":"Daugherty SE","year":"2021","unstructured":"Daugherty SE, Guo Y, Heath K, et al.. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021, 373:n1098. 10.1136\/bmj.n1098","journal-title":"BMJ"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2023.06.002","article-title":"Incidence and predictors of development of new onset hypertension post COVID-19 disease","volume":"75","author":"Vyas P","year":"2023","unstructured":"Vyas P, Joshi D, Sharma V, Parmar M, Vadodariya J, Patel K, Modi G. Incidence and predictors of development of new onset hypertension post COVID-19 disease. Indian Heart J. 2023, 75:347-51. 10.1016\/j.ihj.2023.06.002","journal-title":"Indian Heart J"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s40292-023-00574-5","article-title":"Risk of incident new-onset arterial hypertension after COVID-19 recovery: a systematic review and meta-analysis","volume":"30","author":"Zuin M","year":"2023","unstructured":"Zuin M, Rigatelli G, Bilato C, Pasquetto G, Mazza A. Risk of incident new-onset arterial hypertension after COVID-19 recovery: a systematic review and meta-analysis. High Blood Press Cardiovasc Prev. 2023, 30:227-33. 10.1007\/s40292-023-00574-5","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03553-9","article-title":"High-dimensional characterization of post-acute sequelae of COVID-19","volume":"594","author":"Al-Aly Z","year":"2021","unstructured":"Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021, 594:259-64. 10.1038\/s41586-021-03553-9","journal-title":"Nature"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2023.03.002","article-title":"Long COVID: pathophysiological factors and abnormalities of coagulation","volume":"34","author":"Turner S","year":"2023","unstructured":"Turner S, Khan MA, Putrino D, Woodcock A, Kell DB, Pretorius E. Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol Metab. 2023, 34:321-44. 10.1016\/j.tem.2023.03.002","journal-title":"Trends Endocrinol Metab"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01579-5","article-title":"Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID\/post-acute sequelae of COVID-19 (PASC)","volume":"21","author":"Pretorius E","year":"2022","unstructured":"Pretorius E, Venter C, Laubscher GJ, et al.. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID\/post-acute sequelae of COVID-19 (PASC). Cardiovasc Diabetol. 2022, 21:148. 10.1186\/s12933-022-01579-5","journal-title":"Cardiovasc Diabetol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga Z","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, et al.. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020, 395:1417-18. 10.1016\/S0140-6736(20)30937-5","journal-title":"Lancet"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.745758","article-title":"Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study","volume":"8","author":"Charfeddine S","year":"2021","unstructured":"Charfeddine S, Ibn Hadj Amor H, Jdidi J, et al.. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front Cardiovasc Med. 2021, 8:745758. 10.3389\/fcvm.2021.745758","journal-title":"Front Cardiovasc Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008762","article-title":"Antibody-induced procoagulant platelets in severe COVID-19 infection","volume":"137","author":"Althaus K","year":"2021","unstructured":"Althaus K, Marini I, Zlamal J, et al.. Antibody-induced procoagulant platelets in severe COVID-19 infection. Blood. 2021, 137:1061-71. 10.1182\/blood.2020008762","journal-title":"Blood"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154886","article-title":"The intersection of COVID-19 and autoimmunity","volume":"131","author":"Knight JS","year":"2021","unstructured":"Knight JS, Caricchio R, Casanova JL, et al.. The intersection of COVID-19 and autoimmunity. J Clin Invest. 2021, 131:154886. 10.1172\/JCI154886","journal-title":"J Clin Invest"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.060785","article-title":"Association of COVID-19 with major arterial and venous thrombotic diseases: a population-wide cohort study of 48 million adults in England and Wales","volume":"146","author":"Knight R","year":"2022","unstructured":"Knight R, Walker V, Ip S, et al.. Association of COVID-19 with major arterial and venous thrombotic diseases: a population-wide cohort study of 48 million adults in England and Wales. Circulation. 2022, 146:892-906. 10.1161\/CIRCULATIONAHA.122.060785","journal-title":"Circulation"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"28","author":"Xie Y","year":"2022","unstructured":"Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022, 28:583-90. 10.1038\/s41591-022-01689-3","journal-title":"Nat Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15267","article-title":"Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response","volume":"19","author":"Townsend L","year":"2021","unstructured":"Townsend L, Fogarty H, Dyer A, et al.. Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J Thromb Haemost. 2021, 19:1064-70. 10.1111\/jth.15267","journal-title":"J Thromb Haemost"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2022-0050","article-title":"Association between D-dimer levels and post-acute sequelae of SARS-CoV-2\u00a0in patients from a tertiary care center","volume":"16","author":"Kalaivani MK","year":"2022","unstructured":"Kalaivani MK, Dinakar S. Association between D-dimer levels and post-acute sequelae of SARS-CoV-2\u00a0in patients from a tertiary care center. Biomark Med. 2022, 16:833-8. 10.2217\/bmm-2022-0050","journal-title":"Biomark Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26575","article-title":"Hypercoagulability, endotheliopathy, and inflammation approximating 1\u2009year after recovery: assessing the long-term outcomes in COVID-19 patients","volume":"97","author":"Fan BE","year":"2022","unstructured":"Fan BE, Wong SW, Sum CL, et al.. Hypercoagulability, endotheliopathy, and inflammation approximating 1\u2009year after recovery: assessing the long-term outcomes in COVID-19 patients. Am J Hematol. 2022, 97:915-23. 10.1002\/ajh.26575","journal-title":"Am J Hematol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3390\/hemato3010010","article-title":"Persisting endothelial cell activation and hypercoagulability after COVID-19 recovery - the prospective observational ROADMAP-post COVID-19 study","volume":"3","author":"Gerotziafas GT","year":"2022","unstructured":"Gerotziafas GT, Van Dreden P, Sergentanis TN, et al.. Persisting endothelial cell activation and hypercoagulability after COVID-19 recovery - the prospective observational ROADMAP-post COVID-19 study. Hemato. 2022, 3:111-21. 10.3390\/hemato3010010","journal-title":"Hemato"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00146-0","article-title":"Sustained prothrombotic changes in convalescent patients with COVID-19","volume":"8","author":"von Meijenfeldt FA","year":"2021","unstructured":"von Meijenfeldt FA, Th\u00e5lin C, Lisman T. Sustained prothrombotic changes in convalescent patients with COVID-19. Lancet Haematol. 2021, 8:e475. 10.1016\/S2352-3026(21)00146-0","journal-title":"Lancet Haematol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvdsp.2021.10.007","article-title":"Sulodexide in the treatment of patients with long COVID 19 symptoms and endothelial dysfunction: the results of TUN-EndCOV study","volume":"14","author":"Charfeddine S","year":"2021","unstructured":"Charfeddine S, Ibn Hadjamor H, Torjmen S, et al.. Sulodexide in the treatment of patients with long COVID 19 symptoms and endothelial dysfunction: the results of TUN-EndCOV study. Archives of Cardiovascular Diseases Supplements. 2021, 14:127. 10.1016\/j.acvdsp.2021.10.007","journal-title":"Archives of Cardiovascular Diseases Supplements"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14849","article-title":"Dual inhibition of cannabinoid CB(1) receptor and inducible NOS attenuates obesity-induced chronic kidney disease","volume":"177","author":"Udi S","year":"2020","unstructured":"Udi S, Hinden L, Ahmad M, et al.. Dual inhibition of cannabinoid CB(1) receptor and inducible NOS attenuates obesity-induced chronic kidney disease. Br J Pharmacol. 2020, 177:110-27. 10.1111\/bph.14849","journal-title":"Br J Pharmacol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1007636","article-title":"The potential of heparin-induced extracorporeal LDL\/fibrinogen precipitation (H.E.L.P.)-apheresis for patients with severe acute or chronic COVID-19","volume":"9","author":"Jaeger BR","year":"2022","unstructured":"Jaeger BR, Arron HE, Kalka-Moll WM, Seidel D. The potential of heparin-induced extracorporeal LDL\/fibrinogen precipitation (H.E.L.P.)-apheresis for patients with severe acute or chronic COVID-19. Front Cardiovasc Med. 2022, 9:1007636. 10.3389\/fcvm.2022.1007636","journal-title":"Front Cardiovasc Med"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103412","article-title":"Effects of therapeutic interventions on long COVID: a meta-analysis of randomized controlled trials","volume":"87","author":"Tan C","year":"2025","unstructured":"Tan C, Meng J, Dai X, et al.. Effects of therapeutic interventions on long COVID: a meta-analysis of randomized controlled trials. EClinicalMedicine. 2025, 87:103412. 10.1016\/j.eclinm.2025.103412","journal-title":"EClinicalMedicine"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/414406-chronic-cardiovascular-disorders-associated-with-covid-19-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T12:41:06Z","timestamp":1758890466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/414406-chronic-cardiovascular-disorders-associated-with-covid-19-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":55,"URL":"https:\/\/doi.org\/10.7759\/cureus.93271","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,26]]}}}